← Leaderboards
Jillian M Richmond
Tufts University Boston
$1,328,254
Attributed
$2,656,507
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $684K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,656,507 · 1
By mechanism
U01$2,656,507 · 1
Top collaborators
- Cheryl A London5 shared
Most similar at Tufts University Boston
Same institution · by research overlap
- Charles Bix Shoemaker$9,649,281
- Joe Sorg$9,025,831
- James E Schwob$23,206,425
- F. Rob Jackson$15,913,842
- Aimee Shen$10,504,650
Others in their field
Other Rising Stars on “Activities Of Daily Living”
- Jennifer Lee O'Brien · University Of South Florida$15,110,862
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Karen A. Stark · Digital Infuzion, Inc.$3,804,755
- Hailey Rose Banack · State University Of New York At Buffalo$3,615,603
- Marco Capogrosso · University Of Pittsburgh At Pittsburgh$3,027,117
- Sebastian Tong · University Of Washington$2,998,489
Research focus
Activities Of Daily LivingCell Free DnaAmputationAdjuvantAgonistAntigen-Presenting CellsAntigensAntigen-Specific T CellsAnti-Tumor Immune ResponseAnimal Cancer ModelAnimal ModelBiobankBioinformaticsBiologicalBiological MarkersBiological ModelsBloodCancer GenomeCancer ModelCanis FamiliarisCarboplatinCcr1 GeneCd8-Positive T-LymphocytesCells
Grant awards (5)
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$592,532
U01 · FY2025 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$76,725
U01 · FY2025 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$683,986
U01 · FY2024 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$657,791
U01 · FY2023 · CA
Generation of tumor specific immunity in canine osteosarcoma through dendritic cell hyperactivation$645,473
U01 · FY2022 · CA